proxyvotesnow.com

Home › Companies › COGENT BIOSCIENCES INC. › 2024-2025

COGENT BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and COGENT BIOSCIENCES INC.’s Form 8-K, filed 2025-06-05 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 5Ballot items
  • 173Asset managers
  • 935Fund votes
  • 2025-06-04Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore COGENT BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by COGENT BIOSCIENCES INC.

These tallies are COGENT BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

COGENT BIOSCIENCES INC. — official shareholder meeting results, meeting held 2025-06-04
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: • Dr. Karen Ferrante 68,418,781---- 22,231,56410,575,051 Majority: yes
Elect Director: • Matthew E. Ros 77,274,345---- 13,376,00010,575,051 Majority: yes
Proposal 2: Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm 101,115,649104,2685,479 --0 Majority: yes
Proposal 3: Advisory Vote on Executive Compensation 89,797,699808,71543,931 --10,575,051 Majority: yes
Proposal 4: Approval of an Amendment to the Certificate of Incorporation to Provide for Officer Exculpation 86,181,3734,422,46246,510 --10,575,051 Majority: yes

Source: COGENT BIOSCIENCES INC., Form 8-K, filed with the SEC on 2025-06-05 — read the filing on EDGAR.

How asset managers voted at the COGENT BIOSCIENCES INC. 2024-2025 meeting

Each item below shows how the 173 asset managers that disclosed a COGENT BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 89,797,699AGAINST: 808,715

COGENT BIOSCIENCES INC.’s own tally for this item (“Proposal 3: Advisory Vote on Executive Compensation”): 89,797,699 for, 808,715 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,856,454 outstanding shares: 79% for, 0.8% against (80% of the company cast a for/against vote).

The 172 asset managers below cast 99.7% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 94%
FOR: 94.4%AGAINST: 0.2%ABSTAIN: 5.3%
Largest asset managers voting on “Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity33,410,7200 00For
Paradigm Biocapital Advisors LP8,315,8780 00For
Commodore Capital LP8,147,1560 00For
BlackRock7,199,52520,812 00For
TCG Crossover Management, LLC6,964,3750 00For
Kynam Capital Management, LP00 6,690,1280Abstain
Fairmount Funds Management LLC6,225,6410 00For
Vanguard6,216,6120 00For
VR Adviser, LLC5,684,4110 00For
State Street5,325,2171,266 00For
Octagon Capital Advisors LP2,763,0000 00For
DEERFIELD MANAGEMENT COMPANY, L.P.2,640,2140 00For
GEODE CAPITAL MANAGEMENT, LLC2,405,6460 00For
Redmile Group, LLC2,310,6260 00For
Vestal Point Capital, LP1,943,9310 00For
Frazier Life Sciences Management, L.P.1,737,6010 00For
Charles Schwab1,666,8340 00For
Woodline Partners LP1,646,8010 00For
Nantahala Capital Management, LLC1,497,3870 00For
Sofinnova Investments, Inc.1,431,7700 00For
FRANKLIN ADVISERS INC1,326,3820 00For
Vivo Capital, LLC1,122,4710 00For
Northern Trust792,4440 00For
Saturn V Capital Management LP665,3060 00For
Point72653,1590 00For

Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.

2. APPROVAL OF AN AMENDMENT OF THE COMPANY'S CERTIFICATE OF INCORPORATION TO PROVIDE FOR OFFICER EXCULPATION.

SHAREHOLDER RIGHTS AND DEFENSESMajority of the votes cast: yes

95% Majority: yes · of votes cast

FOR 95%
FOR: 86,181,373AGAINST: 4,422,462

COGENT BIOSCIENCES INC.’s own tally for this item (“Proposal 4: Approval of an Amendment to the Certificate of Incorporation to Provide for Officer Exculpation”): 86,181,373 for, 4,422,462 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,856,454 outstanding shares: 76% for, 4% against (80% of the company cast a for/against vote).

The 45 asset managers below cast 98% of the shares they voted on this item FOR (30,710,800 for, 712,083 against).

FOR 98%
FOR: 30,710,800 (97.7%)AGAINST: 712,083 (2.3%)
Largest asset managers voting on “APPROVAL OF AN AMENDMENT OF THE COMPANY'S CERTIFICATE OF INCORPORATION TO PROVIDE FOR OFFICER EXCULPATION.” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,9920 00For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street1,827,401682 00For
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES0481,629 00Against
Dimensional278,5890 00For
Equitable246,6300 00For
TIAA230,9000 00For
Delaware/Macquarie230,0000 00For
Exchange Place Advisors Trust8,127159,221 00Against
Direxion Shares ETF Trust92,5660 00For
Tema ETF Trust72,3700 00For
Lincoln Financial70,5780 00For
Global X053,448 00Against
ProShares53,0880 00For
Northern Trust52,0440 00For
AIG/SunAmerica46,8750 00For
John Hancock34,0420 00For
Pacific Life29,9220 00For
Nationwide23,0772,760 00For
Brighthouse25,3230 00For
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I14,7370 00For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

3. Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Karen Ferrante

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD 25%
FOR: 68,418,781WITHHELD: 22,231,564

COGENT BIOSCIENCES INC.’s own tally for this item (“Elect Director: • Dr. Karen Ferrante”): 68,418,781 for, 22,231,564 withheld, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,856,454 outstanding shares: 60% for, 20% withheld (80% of the company cast a for/withheld vote).

The 45 asset managers below cast 100% of the shares they voted on this item FOR (27,824,681 for, 0 against).

FOR 89%11%
FOR: 27,824,681 (88.5%)ABSTAIN: 3,598,202 (11.5%)
Largest asset managers voting on “Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,6990 2930For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street4,6690 1,823,4140Abstain
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES00 481,6290Abstain
Dimensional00 278,5890Abstain
Equitable164,5700 82,0600For
TIAA230,9000 00For
Delaware/Macquarie00 230,0000Abstain
Exchange Place Advisors Trust00 167,3480Abstain
Direxion Shares ETF Trust00 92,5660Abstain
Tema ETF Trust72,3700 00For
Lincoln Financial00 70,5780Abstain
Global X00 53,4480Abstain
ProShares00 53,0880Abstain
Northern Trust00 52,0440Abstain
AIG/SunAmerica00 46,8750Abstain
John Hancock00 34,0420Abstain
Pacific Life29,9220 00For
Nationwide25,8370 00For
Brighthouse00 25,3230Abstain
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I00 14,7370Abstain

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

4. Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Matthew E. Ros

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%WITHHELD 15%
FOR: 77,274,345WITHHELD: 13,376,000

COGENT BIOSCIENCES INC.’s own tally for this item (“Elect Director: • Matthew E. Ros”): 77,274,345 for, 13,376,000 withheld, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,856,454 outstanding shares: 68% for, 12% withheld (80% of the company cast a for/withheld vote).

The 45 asset managers below cast 100% of the shares they voted on this item FOR (30,487,797 for, 0 against).

FOR 97%
FOR: 30,487,797 (97.0%)ABSTAIN: 935,086 (3.0%)
Largest asset managers voting on “Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,6990 2930For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street1,825,8020 2,2810For
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES481,6290 00For
Dimensional00 278,5890Abstain
Equitable164,5700 82,0600For
TIAA230,9000 00For
Delaware/Macquarie00 230,0000Abstain
Exchange Place Advisors Trust159,2210 8,1270For
Direxion Shares ETF Trust00 92,5660Abstain
Tema ETF Trust72,3700 00For
Lincoln Financial68,1000 2,4780For
Global X53,4480 00For
ProShares00 53,0880Abstain
Northern Trust52,0440 00For
AIG/SunAmerica00 46,8750Abstain
John Hancock00 34,0420Abstain
Pacific Life29,9220 00For
Nationwide25,8370 00For
Brighthouse00 25,3230Abstain
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I00 14,7370Abstain

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

5. Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 101,115,649AGAINST: 104,268

COGENT BIOSCIENCES INC.’s own tally for this item (“Proposal 2: Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm”): 101,115,649 for, 104,268 against, per its Form 8-K filed 2025-06-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 113,856,454 outstanding shares: 89% for, 0.1% against (89% of the company cast a for/against vote).

The 45 asset managers below cast 99.9% of the shares they voted on this item FOR (31,422,171 for, 712 against).

FOR 99.9%
FOR: 31,422,171 (100.0%)AGAINST: 712 (0.0%)
Largest asset managers voting on “Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public acc” at COGENT BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fidelity16,608,9920 00For
Vanguard5,988,5430 00For
BlackRock3,807,6570 00For
State Street1,827,99390 00For
Charles Schwab832,0630 00For
FRANKLIN STRATEGIC SERIES481,6290 00For
Dimensional278,5890 00For
Equitable246,6300 00For
TIAA230,9000 00For
Delaware/Macquarie230,0000 00For
Exchange Place Advisors Trust167,3480 00For
Direxion Shares ETF Trust92,5660 00For
Tema ETF Trust72,3700 00For
Lincoln Financial70,5780 00For
Global X53,4480 00For
ProShares53,0880 00For
Northern Trust52,0440 00For
AIG/SunAmerica46,8750 00For
John Hancock34,0420 00For
Pacific Life29,9220 00For
Nationwide25,8370 00For
Brighthouse25,3230 00For
T. Rowe Price21,7740 00For
Bridge Builder Trust19,6000 00For
ETFis Series Trust I14,7370 00For

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Largest COGENT BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked by the number of COGENT BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 113,856,454 shares outstanding at the time of that meeting.

Top COGENT BIOSCIENCES INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Fidelity 29.34%
2Paradigm Biocapital Advisors LP 7.30%
3Commodore Capital LP 7.16%
4BlackRock 6.34%
5TCG Crossover Management, LLC 6.12%
6Kynam Capital Management, LP 5.88%
7Fairmount Funds Management LLC 5.47%
8Vanguard 5.46%
9VR Adviser, LLC 4.99%
10State Street 4.68%

Reported COGENT BIOSCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

COGENT BIOSCIENCES INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
FMR (Fidelity) 15.00% 13F
Entities affiliated with FMR LLC 14.55% DEF14A
Fairmount Funds Management LLC 13.49% 13D
Entities affiliated with Fairmount Funds Management LLC 10.39% DEF14A
Entities affiliated with Commodore Capital LP 9.22% DEF14A
Entities affiliated with Point72 Asset Management, L.P. 8.77% DEF14A
Entities affiliated with Kynam Capital Management, LP 8.12% DEF14A
Deerfield Mgmt, L.P. 7.94% 13G
BlackRock 7.18% 13F
Entities affiliated with TCG Crossover Fund I, L.P. 6.12% DEF14A

Percentages above are of 113,856,454 shares outstanding, as reported by COGENT BIOSCIENCES INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from COGENT BIOSCIENCES INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At COGENT BIOSCIENCES INC.'s shareholder meeting held 2025-06-04, in the 2024-2025 proxy season, 173 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 935 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the compensation of the Company's named… — FOR was 99.1% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: COGENT BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-05.

COGENT BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.